Overall, we found that the levels of the three proteins were significantly different than normal values in patients at risk of NAFLD without T2DM, with increased A2M, decreased ApoA1, and increased haptoglobin. This evidence concerns the gene A2M and metabolic dysfunction-associated steatotic liver disease.